These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2863362)

  • 21. Rate-controlled rectal absorption enhancement of cefoxitin by co-administration of sodium salicylate or sodium octanoate in healthy volunteers.
    Van Hoogdalem EJ; Wackwitz AT; De Boer AG; Cohen AF; Breimer DD
    Br J Clin Pharmacol; 1989 Jan; 27(1):75-81. PubMed ID: 2706190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of phenothiazines to enhance the rectal absorption of water-soluble compounds.
    Fix JA; Leppert PS; Porter PA; Alexander J
    J Pharm Pharmacol; 1984 Apr; 36(4):286-8. PubMed ID: 6144788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3-Amino-1-hydroxypropylidene-1,1-diphosphonate (APD): a novel enhancer of rectal cefoxitin absorption in rats.
    van Hoogdalem EJ; Wackwitz AT; de Boer AG; Breimer DD
    J Pharm Pharmacol; 1989 May; 41(5):339-41. PubMed ID: 2569522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rectal absorption of dextran in rats in the presence of salicylates.
    West GB
    Int Arch Allergy Appl Immunol; 1982; 68(3):283-5. PubMed ID: 6177646
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetics and body fluid and endometrial concentrations of cefoxitin in mares.
    Brown MP; Gronwall RR; Houston AE
    Am J Vet Res; 1986 Aug; 47(8):1734-8. PubMed ID: 3752682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of salicylate and other enhancers on rectal absorption of erythropoietin in rats.
    Mizuno A; Ueda M; Kawanishi G
    J Pharm Pharmacol; 1992 Jul; 44(7):570-3. PubMed ID: 1357136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of triglyceride on small intestinal absorption of cefoxitin in rats.
    Yoshitomi H; Nishihata T; Frederick G; Dillsaver M; Higuchi T
    J Pharm Pharmacol; 1987 Nov; 39(11):887-91. PubMed ID: 2892911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the effects of hyperosmotic salicylate solutions in closed and perfused rectal in-situ loops of rats.
    Derrick GM; Thomas NW; Wilson CG
    J Pharm Pharmacol; 1986 Jun; 38(6):484-6. PubMed ID: 2873231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphatic uptake of water-soluble drugs after rectal administration.
    Caldwell L; Nishihata T; Rytting JH; Higuchi T
    J Pharm Pharmacol; 1982 Aug; 34(8):520-2. PubMed ID: 6126565
    [No Abstract]   [Full Text] [Related]  

  • 30. Absorption enhancement of rectally infused cefoxitin by medium chain monoglycerides in conscious rats.
    Watanabe Y; van Hoogdalem EJ; de Boer AG; Breimer DD
    J Pharm Sci; 1988 Oct; 77(10):847-9. PubMed ID: 3236226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cefoxitin serum and uterine concentrations following a two-gram intramuscular dose.
    Hemsell DL; Birkett I; Reveley L; Bland JA
    Obstet Gynecol; 1982 Feb; 59(2):149-52. PubMed ID: 7078858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacokinetics of cefuroxime and cefoxitin in experimentally induced pleurisy in the rat].
    Benoni G; Franco L; Conforti A; Totorizzo A; Velo GP
    G Ital Chemioter; 1981; 28(1-2):33-9. PubMed ID: 7347703
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies of the concentration of cefoxitin in oro-maxillary tissues and serum (author's transl)].
    Saito K; Fujii K; Aoki S; Michi K; Ueno T; Hashimoto K; Iwaki H; Shimizu M; Shioda S
    Jpn J Antibiot; 1982 Mar; 35(3):845-9. PubMed ID: 7097984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraoperative serum and tissue activity of cefazolin and cefoxitin.
    DiPiro JT; Vallner JJ; Bowden TA; Clark BA; Sisley JF
    Arch Surg; 1985 Jul; 120(7):829-32. PubMed ID: 3160322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of sodium salicylate on permeability of connective tissue in the intact and adrenalectomized rat].
    JACOT B; DUCOMMUN P; TIMIRAS PS; SELYE H
    J Physiol (Paris); 1951; 43(4):621-3. PubMed ID: 14918074
    [No Abstract]   [Full Text] [Related]  

  • 36. Topical effects of absorption enhancing agents on the rectal mucosa of rats in vivo.
    van Hoogdalem EJ; Vermeij-Kerrs C; de Boer AG; Breimer DD
    J Pharm Sci; 1990 Oct; 79(10):866-70. PubMed ID: 2280353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sodium pump activity and norepinephrine responsiveness of femoral arterial smooth muscle from DOCA-salt rats.
    Soltis EE; Field FP
    Pharmacology; 1987; 34(2-3):104-10. PubMed ID: 3588654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impeded interstitial fluid movement: a factor in pancreatic oedema.
    Papp M; Makara GB; Folly G
    Lymphology; 1975 Dec; 8(4):148-53. PubMed ID: 1214510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pentobarbital sodium inhibits calcium uptake in vascular smooth muscle.
    Altura BT; Turlapaty PD; Altura BM
    Biochim Biophys Acta; 1980 Jan; 595(2):309-12. PubMed ID: 7353000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vanadate effect on the Na,K-ATPase and the Na-K pump in in vitro-grown rat vascular smooth muscle cells.
    Searle BM; Higashino H; Khalil F; Bogden JD; Tokushige A; Tamura H; Kino M; Aviv A
    Circ Res; 1983 Aug; 53(2):186-91. PubMed ID: 6309430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.